Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan
- PMID: 22763459
- PMCID: PMC4164151
- DOI: 10.1007/s10903-012-9662-y
Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan
Abstract
Prostate cancer is the most common cancer among men in the United States with striking differences in incidence and mortality among ethnic groups. Michigan has one of the largest concentrations of Arab Americans (AAs) in the U.S. and little is known about this ethnic minority with respect to prostate cancer. This study investigated differences in clinical profile, quality of care, and recurrence among prostate cancer survivors comparing AAs and Caucasian Americans (CAs). Participants in this study included 2499 prostate cancer survivors from the Michigan Cancer Registry from 1985 to 2004. Participants completed surveys regarding health-seeking behavior, post-treatment symptoms, quality of care and recurrence. Ethnicity was self-reported and AAs and CAs were compared with respect to clinical profile, quality of care, and recurrence. There were 52 AAs and 1886 CAs patients with AAs being younger ([Formula: see text] age 68.3 ± SD 21.4 years, [Formula: see text] age 72.3 ± SD 14.1 years, for AAs and CAs, respectively) (P = 0.05). AAs had lower socioeconomic standard than CAs (34 vs. 10.6 %, <$20,000 yearly income/year; for AAs vs. CAs, respectively) (P < 0.0001). AAs reported poorer health than AAs (7.7 vs. 3.0 % for AAs vs. CAs, respectively) (P < 0.0001). AAs were more likely to visit specialists for prostate follow-up (44.5 vs. 19.7 % visited a specialist, for AAs vs. CAs respectively) (P < 0.0001) and received supplementary healthcare workers (13 % of AAs vs. 3.1 % CAs) (P = 0.032). In addition, AAs reported higher occurrence of urinary incontinence compared to CAs (67.4 vs. 60.4 %, for AAs vs. CAs, respectively) (P = 0.001). Ethnic background was not a predictor of recurrence [(Odds ratio (OR) = 1.1 (95 % confidence intervals CI = 0.40, 2.9)] (P = 0.873) even after adjusting for age, PSA levels within the last 2 years, metastasis and hormonal therapy. While AAs prostate cancer patients were different from CAs in age, income, seeking medical care, and health reporting, ethnic background was not a predictor of recurrence. Future studies of the impact of socioeconomic, demographic and cultural factors, and health care seeking behavior on long-term survival of prostate cancer in AAs and other ethnic minorities are warranted.
Similar articles
-
Infant mortality among Arab-Americans: findings from the Arab-American birth outcomes study.Matern Child Health J. 2013 May;17(4):732-45. doi: 10.1007/s10995-012-1049-0. Matern Child Health J. 2013. PMID: 22706996
-
Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.J Cancer Surviv. 2014 Mar;8(1):121-30. doi: 10.1007/s11764-013-0312-8. Epub 2013 Nov 10. J Cancer Surviv. 2014. PMID: 24214413
-
Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.Int Urol Nephrol. 2006;38(1):33-44. doi: 10.1007/s11255-005-3619-1. Int Urol Nephrol. 2006. PMID: 16502050
-
Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):51-9. doi: 10.1016/s0360-3016(00)01365-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163497 Review.
-
Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.J S C Med Assoc. 2006 Aug;102(7):241-9. J S C Med Assoc. 2006. PMID: 17319238 Review.
Cited by
-
Clinicopathological features, treatment and outcome of Omani patients with localised prostate cancer.Arab J Urol. 2020 Jul 6;18(4):219-225. doi: 10.1080/2090598X.2020.1781386. Arab J Urol. 2020. PMID: 33312732 Free PMC article.
-
Perspectives of multisectoral community stakeholders on Arab American cancer patients' needs and suggested interventions.Support Care Cancer. 2021 Oct;29(10):5915-5925. doi: 10.1007/s00520-021-06169-x. Epub 2021 Mar 24. Support Care Cancer. 2021. PMID: 33763724
-
The Health of Arab Americans in the United States: An Updated Comprehensive Literature Review.Front Public Health. 2018 Sep 11;6:262. doi: 10.3389/fpubh.2018.00262. eCollection 2018. Front Public Health. 2018. PMID: 30255009 Free PMC article.
-
Arab, Middle Eastern, and North African Health Disparities Research: A Scoping Review.J Racial Ethn Health Disparities. 2025 Jun;12(3):1397-1415. doi: 10.1007/s40615-024-01972-8. Epub 2024 Mar 11. J Racial Ethn Health Disparities. 2025. PMID: 38466512
References
-
- Seer U. 2011 2/16/2011. Available from: http://www.seer.cancer.gov.
-
- ACS. 2011 4/3/2011. Available from: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/can....
-
- Jones BA, et al. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Preven. 2008;17(10):2825–2834. - PubMed
-
- Arab American Institute Foundation. Washington, DC: Arab American Institute Foundation; 2011. Michigan: State’s rank by Arab American population: Census estimate of Arab American population.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous